Earnings

Enfusion (ENFN) Earnings Release Scheduled for November 4th

Published November 3, 2024

Enfusion (NYSE:ENFN – Get Free Report) is set to release its quarterly earnings report before the market opens on Monday, November 4th. Analysts are forecasting that the company will report earnings of $0.06 per share for the quarter. Additionally, Enfusion has provided guidance for FY 2024.

For those interested in participating, registration for the company’s earnings conference call is available through a provided link.

In its previous earnings report, released on August 6th, Enfusion disclosed earnings of $0.02 per share, which fell short of analysts’ expectations of $0.03 by $0.01. The company achieved a return on equity of 6.17%, with a net margin of 1.98%. Revenue for that quarter totaled $49.46 million, slightly below the projected $50.27 million. Analysts expect Enfusion to report $0 EPS for both the current and the next fiscal year on average.

Stock Performance

On Friday, Enfusion shares opened at $9.05, reflecting a gain of 1.6%. The company's market capitalization is at $1.16 billion, with a price-to-earnings ratio of 226.31, a PEG ratio of 2.50, and a beta value of 0.92. The fifty-day simple moving average for the stock stands at $8.75, while the 200-day average is $8.85. Enfusion's stock has experienced a 52-week low of $7.52 and a high of $10.45.

About Enfusion

Enfusion, Inc. offers software-as-a-service solutions for the investment management industry, with services extended across the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company's Portfolio Management System provides a real-time investment book of record, including valuation and risk management tools. These features enable users to analyze portfolio data for chief investment officers and portfolio managers. Additionally, the Order and Execution Management System allows portfolio managers, traders, compliance teams, and analysts to electronically manage trade orders across various asset classes, ensuring adherence to trading regulations and internal guidelines.

Earnings, Stock, Finance